Email Us
View Reports

Antibiotics Market

Antibiotics Market Analysis – By Product Type (Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, Others), By Spectrum (Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics), and By Region – Industry Size, Share, Trends, Growth Analysis and Global Forecast to 2024

  • ID : 21249843  |  
  • Published : Feb-2019  |  
  • Region : Global  |  
  • Pages : 160   |  
  • Publisher : Mordor Intelligence

Antibiotics Market Size Growth Rate:

According to the research report, Antibiotics Market size was valued at USD 42653.89 million in 2018 and this figure estimated to cross USD 56369.92 million by the end of 2024, and it is growing at a CAGR of 4.7% during the forecast period 2019-2024.

The growing threat of drug resistance and a weak pipeline of new molecules are leading to the development of combinational formulations. For instance, in countries like India, the emergence of multi-drug-resistant tuberculosis (TB) is a major factor driving the R&D expenditures. Methicillin-resistant Staphylococcus aureus (MRSA) is another bacterium responsible for several infections in humans that are difficult to treat. The MRSA infection is difficult to treat with standard antibiotics, such as penicillins (methicillin, dicloxacillin, nafcillin, and oxacillin), and the cephalosporins. In 2014, the US Food and Drug Administration (FDA) approved four new antibiotics for the treatment of infections caused by gram-positive bacteria, including MRSA.

Carbapenems are Expected to show the Rapid Growth of in the Future.

The Cephalosporin segment is believed to have the largest market size in the forecast period. Carbapenems are expected to witness the highest CAGR of around 5.9% in the forecast period.

Antibiotics Market Geographical Condition:

North America currently dominates the market for Antibiotics and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future owing to the raised adoption of the Antibiotics. The United States holds the majority of the market in the North America region; this is due to the fact that the United States has the highest antibiotic prescribing rate in the North America region. In addition, there is a rise in per capita health expenditure in the country that is expected to increase over the forecast period owing to the decrease in the unemployment rate.

Competitive Landscape of the Market:

The Antibiotics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices

Some of the promising companies leading the Antibiotics Market:

  1. GlaxoSmithKline Plc.
  2. Johnson & Johnson Inc.
  3. Merck & Co. Inc.
  4. Pfizer Inc.
  5. Bayer AG

This research report includes following segmentation for the Antibiotics Market size and forecast until 2024:

Antibiotics Market – By Product Type:

  • Cephalosporins
  • Penicillins
  • Fluroquinilones
  • Macrolides
  • Carbapenems
  • Aminoglycosides
  • Sulfonamides
  • Others

 Antibiotics Market – By Spectrum:

  • Broad-Spectrum Antibiotics
  • Narrow-Spectrum Antibiotics

 Antibiotics Market – By Geographical Segmentation:

  • North America                                                 

    • United States                                
    • Canada                                          

  • Europe                                                                                  

    • United Kingdom                                            
    • Germany                                       
    • France                                           
    • Italy                                
    • Spain                                             

  • Asia-Pacific                                                      

    • China                                             
    • India                                              
    • Japan                                             
    • South Korea                                  

  • Latin America                                                                              

    • Brazil                                             
    • Argentina                                      
    • Mexico                                          

  • Middle-East & Africa                                                       

    • Middle-East                                  
    • Africa       


1. Study Deliverables

2. Study Assumptions

3. Scope of the Study




1. Market Overview

2. Market Drivers

1. Emergence of Anti-MRSA/VRE Drugs

2. Development of Generic Drugs

3. Vulnerable Aging Population

3. Market Restraints

1. Antibiotic Resistance

2. Fewer Companies Involved in Active Research

3. Time Taken for Regulatory Approval

4. Industry Attractiveness – Porter’s Five Force Analysis


1. By Product Type

1. Cephalosporins

2. Penicillins

3. Fluroquinilones

4. Macrolides

5. Carbapenems

6. Aminoglycosides

7. Sulfonamides

8. Others

2. By Spectrum

1. Broad-Spectrum Antibiotics

2. Narrow-Spectrum Antibiotics

3. Geography

1. North America

1. United States

2. Canada

3. Mexico

2. Europe

1. France

2. Germany

3. United Kingdom

4. Italy

5. Spain

6. Rest of Europe

3. Asia Pacific

1. China

2. Japan

3. India

4. Australia

5. South Korea

6. Rest of Asia-Pacific

4. Middle East and Africa

1. GCC

2. South Africa

3. Rest of Middle East and Africa

5. South America

1. Brazil

2. Argentina

3. Rest of South America


1. Company Profiles

1. GlaxoSmithKline Plc

2. Johnson & Johnson Inc

3. Merck & Co. Inc

4. Pfizer Inc.

5. Bayer Healthcare AG

6. Novartis AG

7. Sanofi SA

8. Abbott Laboratories

9. Roche Holding AG


Purchase this Market Research Report


Call us on : +1 888 709 8757

Drop us an email at :